{"id":10998,"date":"2020-05-12T04:09:57","date_gmt":"2020-05-12T04:09:57","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2549574"},"modified":"2020-05-12T04:09:57","modified_gmt":"2020-05-12T04:09:57","slug":"pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/","title":{"rendered":"PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"149\" height=\"90\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1589256597.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<div class=\"entry-content\">\n<p>In a new report titled &lsquo;<strong>Non-Melanoma Skin Cancer Treatment Market: Global Industry Analysis 2012 &ndash; 2016 and Forecast 2017 &ndash; 2025,<\/strong>&rsquo; Persistence Market Research analyzes the<strong>globalnon-melanoma skin cancer treatment market<\/strong>over an eight year forecast period 2017 &ndash; 2025 and throws light on the various factors impacting revenue growth of the market over the said period.<\/p>\n<p>The report highlights the market forecasts for the different segments and presents deeper insights for informed decision making.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" title=\"Non-Melanoma Skin Cancer Treatment Market \" src=\"http:\/\/www.persistencemarketresearch.com\/images\/non-melanoma-skin-cancer-treatment-market.jpg\" alt=\"non melanoma skin cancer treatment market\" width=\"453\" height=\"219\" \/><\/p>\n<p><strong>Get Sample Copy of Report @<a href=\"https:\/\/www.persistencemarketresearch.com\/samples\/3648\">https:\/\/www.persistencemarketresearch.com\/samples\/3648<\/a><\/strong><\/p>\n<div class=\"col-md-9\">\n<div class=\"col-md-12 rep-dtl-block\">\n<div class=\"tab-content\">\n<div id=\"companies\" class=\"tabContent\">\n<p><strong>Company Profiles<\/strong><\/p>\n<ul>\n<li>Almirall S.A.<\/li>\n<li>Boehringer Ingelheim GmbH<\/li>\n<li>Bristol-Myers Squibb Company<\/li>\n<li>Eli Lilly and Company<\/li>\n<li>Elekta AB<\/li>\n<li>F. Hoffmann-La Roche Ltd.<\/li>\n<li>Merck &amp; Co., Inc.<\/li>\n<li>Novartis AG<\/li>\n<li>Mylan NV<\/li>\n<li>Sun Pharmaceutical Industries Ltd.<\/li>\n<li>Varian Medical Systems, Inc.<\/li>\n<li>Sensus Healthcare<\/li>\n<li>iCAD, Inc.<\/li>\n<li>Accuray, Inc.<\/li>\n<li>Ion Beam Applications SA<\/li>\n<li>Others.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<aside class=\"col-md-3\">\n<div class=\"outer-box full-light-bg-block padT15\">\n<div class=\"request-sample-btn-block\">\n<div class=\"col-md-12 text-center noPadding\">\n<p><strong>Region &ndash; High Prevalence of Non-Melanoma Skin Cancer in North America<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/aside>\n<p>North America is estimated to hold a market share of roughly 55% in the global non-melanoma skin cancer treatment market in 2017 and is anticipated to have the highest attractiveness index of 3.0 during the forecast period.<\/p>\n<p>Non-melanoma skin cancer is more prevalent in senior citizens and the Population Reference Bureau estimates that Americans over the age of 65 will double to almost 100 million by 2060.<\/p>\n<p><strong>Treatment Type &ndash; Radiation Therapy Larger than Chemotherapy and Photodynamic Therapy<\/strong><\/p>\n<p>Radiation therapy is larger than chemotherapy and photodynamic therapy combined, making it imperative for key stakeholders in the non-melanoma skin cancer treatment market to focus on this treatment type. Radiation therapy is poised to be worth more<strong>than US$ 4.7 Bn<\/strong>by end 2025. Within radiation therapy, companies may wish to target superficial radiation therapy.<\/p>\n<p><strong>Get To Know Methodology of Report @<a href=\"https:\/\/www.persistencemarketresearch.com\/methodology\/3648\">https:\/\/www.persistencemarketresearch.com\/methodology\/3648<\/a><\/strong><\/p>\n<p><strong>Indication &ndash; Basal Cell Carcinoma Dominates the Non-Melanoma Skin Cancer Treatment Market<\/strong><\/p>\n<p>Even though squamous cell carcinoma is predicted to record a higher CAGR of 6.4% from 2017-2025, it is unlikely to outpace basal cell carcinoma anytime soon as the latter is likely to value at approx. thrice the size of the former by end 2025.<\/p>\n<p>The attractiveness index of basal cell carcinoma is 1.5, considerably larger than the 0.5 of squamous cell carcinoma during the same period.<\/p>\n<p><strong>End User &ndash; Hospitals Popular Channel in the Non-Melanoma Skin Cancer Treatment Market<\/strong><\/p>\n<p>The treatment modalities for non-melanoma skin cancer usually require expensive radiation therapy. Therefore, hospitals are preferred over ambulatory surgical centers and specialty clinics in the non-melanoma skin cancer treatment market. The hospital segment is expected to reach a value of<strong>US$ 2 Bn in 2017 itself<\/strong>.<\/p>\n<p><strong>Key Findings of the Non-Melanoma Skin Cancer Treatment Market Report<\/strong><\/p>\n<p>Non-melanoma skin cancer places a high economic burden on countries with minimal medical treatment options, particularly at the metastatic stage. Many pharmaceutical companies are now trying to develop treatment options for late-stage non-melanoma skin cancer.<\/p>\n<p>In addition, companies seek to use their existing drugs to effectively tackle squamous cell and basal cell carcinoma. Major players such as Bristol-Myers Squibb, Genentech, and Merck are working on gaining approval for their drugs to treat non-melanoma skin cancer.<\/p>\n<p><strong>Access Full Report @<a href=\"https:\/\/www.persistencemarketresearch.com\/checkout\/3648\">https:\/\/www.persistencemarketresearch.com\/checkout\/3648<\/a><\/strong><\/p>\n<p>Regulatory authorities and governmental bodies worldwide are adopting a number of cost-containment measures in the developed world. They are shifting from a volume to value-based system and this is driven by steps taken by life sciences companies and governments.<\/p>\n<p>The measures include profit and risk sharing, outcome-based pricing, competitive tendering, and price control. The value-based healthcare system strives to achieve maximum value for every dollar spent on healthcare and improve outcomes by way of integrated care pathways.<\/p>\n<p>The system simultaneously levies pricing pressure on medtech and biopharmaceutical companies and could potentially impact R&amp;D investment in crucial, lifesaving medical treatment technologies in the long run.<\/p>\n<\/div>\n<div class=\"entry-content\">\n<p data-reactid=\"45\"><strong>Explore Extensive Coverage of PMR`s<a href=\"https:\/\/www.persistencemarketresearch.com\/category\/life-sciences-transformational-healthcare.asp\">Life Sciences &amp; Transformational Health<\/a>Landscape<\/strong><\/p>\n<p><strong>Eye<\/strong><strong>Health<\/strong><strong>Products Market<\/strong><strong>&ndash;<\/strong>Eye Health Supplements Market Segmented By Eye Care Supplements, Vision Health Products, Eye Care Supplements, Vitamins, And Supplements Eye Nutritional Products.<a href=\"https:\/\/www.persistencemarketresearch.com\/samples\/5465\"><strong>For More Information<\/strong><\/a><strong><\/strong><\/p>\n<p><strong>Medical Image Analysis Software Market<\/strong><strong>&ndash;<\/strong><\/p>\n<p>According to the assessment of Persistence Market Research, the global medical image analysis software market is forecasted to reach a figure of about US$ 3,800 Mn in 2022 and is poised to exhibit a robust CAGR in the period of assessment.<a href=\"https:\/\/www.persistencemarketresearch.com\/samples\/3515\"><strong>For More Information<\/strong><\/a><\/p>\n<p><strong>About us:<\/strong><\/p>\n<p>Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and<a href=\"https:\/\/www.persistencemarketresearch.com\/category\/life-sciences-transformational-healthcare.asp\">market research methodology<\/a>to help businesses achieve optimal performance.<\/p>\n<p>To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.<\/p>\n<p>Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR&rsquo;s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.<\/p>\n<p><strong>Contact us:<\/strong><\/p>\n<p>Ashish Kolte<br \/>\n<a href=\"https:\/\/www.persistencemarketresearch.com\/\"><strong>Persistence Market Research<\/strong><\/a><br \/>\nAddress &ndash; 305 Broadway, 7th FloorNew York City,<br \/>\nNY 10007 United States<br \/>\nU.S. Ph. &ndash; +1-646-568-7751<br \/>\nUSA-Canada Toll-free &ndash; +1 800-961-0353<br \/>\n<strong>Sales<\/strong>&ndash;<a href=\"mailto:sales@persistencemarketresearch.com\">sales@persistencemarketresearch.com<\/a><br \/>\n<strong>Website<\/strong>&ndash;<a href=\"https:\/\/www.persistencemarketresearch.com\/\">https:\/\/www.persistencemarketresearch.com<\/a><\/p>\n<\/div>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/non-melanoma-skin-cancer-market-demand\/\" rel=\"tag\">Non Melanoma Skin Cancer Market Demand<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/non-melanoma-skin-cancer-market-development\/\" rel=\"tag\">Non Melanoma Skin Cancer Market Development<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/non-melanoma-skin-cancer-market-forecast\/\" rel=\"tag\">Non Melanoma Skin Cancer Market Forecast<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/non-melanoma-skin-cancer-market-growth\/\" rel=\"tag\">Non Melanoma Skin Cancer Market Growth<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/non-melanoma-skin-cancer-market-revenue-share\/\" rel=\"tag\">Non Melanoma Skin Cancer Market Revenue Share<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/non-melanoma-skin-cancer-market-size\/\" rel=\"tag\">Non Melanoma Skin Cancer Market Size<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/non-melanoma-skin-cancer-market-supply\/\" rel=\"tag\">Non Melanoma Skin Cancer Market Supply<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/non-melanoma-skin-cancer-market-trends\/\" rel=\"tag\">Non Melanoma Skin Cancer Market Trends<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/non-melanoma-skin-cancer-market-analysis\/\" rel=\"tag\">Non Melanoma Skin Cancer Market Analysis<\/a><\/p>\n<div><strong>See Campaign: <\/strong><a href=\"http:\/\/www.persistencemarketresearch.com\/market-research\/non-melanoma-skin-cancer-market.asp\" target=\"_blank\">http:\/\/www.persistencemarketresearch.com\/market-research\/non-melanoma-skin-cancer-market.asp<\/a><br \/><b>Contact Information:<\/b><\/p>\n<p>305 Broadway, 7th Floor<br \/>New York City, NY 10007<br \/>United States<br \/><strong>Ph.no.<\/strong> +1-646-568-7751<br \/><strong>E-mail id- <a href=\"mailto:sales@persistencemarketresearch.com\">sales@persistencemarketresearch.com<\/a><\/strong><br \/><strong>Website: <a href=\"https:\/\/www.persistencemarketresearch.com\">https:\/\/www.persistencemarketresearch.com<\/a><\/strong><\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p><p>305 Broadway, 7th Floor<br \/>New York City, NY 10007<br \/>United States<br \/><strong>Ph.no.<\/strong> +1-646-568-7751<br \/><strong>E-mail id- <a href=\"mailto:sales@persistencemarketresearch.com\">sales@persistencemarketresearch.com<\/a><\/strong><br \/><strong>Website: <a href=\"https:\/\/www.persistencemarketresearch.com\/\">https:\/\/www.persistencemarketresearch.com<\/a><\/strong><\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"149\" height=\"90\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1589256597.png\" alt=\"\">In a new report titled &lsquo;Non-Melanoma Skin Cancer Treatment Market: Global Industry Analysis 2012 &ndash; 2016 and Forecast 2017 &ndash; 2025,&rsquo; Persistence Market Research analyzes the&nbsp;global&nbsp;non-melanoma skin cancer treatment market&nbsp;over an eight year forecast period 2017 &ndash; 2025 and throws light on the various factors impacting revenue growth of the market over the said period. &hellip; <a href=\"https:\/\/icrowdnewswire.com\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/\">Continue reading <span>PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025<\/span><\/a> <a href=\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":62,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,5,4],"tags":[],"class_list":["post-10998","post","type-post","status-publish","format-standard","hentry","category-english","category-extended-distribution","category-research-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025 - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025 - Business\" \/>\n<meta property=\"og:description\" content=\"In a new report titled &lsquo;Non-Melanoma Skin Cancer Treatment Market: Global Industry Analysis 2012 &ndash; 2016 and Forecast 2017 &ndash; 2025,&rsquo; Persistence Market Research analyzes the&nbsp;global&nbsp;non-melanoma skin cancer treatment market&nbsp;over an eight year forecast period 2017 &ndash; 2025 and throws light on the various factors impacting revenue growth of the market over the said period. &hellip; Continue reading PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025 Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-12T04:09:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1589256597.png\" \/>\n<meta name=\"author\" content=\"PersistenceMR\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"PersistenceMR\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/\",\"name\":\"PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025 - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1589256597.png\",\"datePublished\":\"2020-05-12T04:09:57+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/6b713e3e642aff8d034fb2ac17ade840\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1589256597.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1589256597.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/6b713e3e642aff8d034fb2ac17ade840\",\"name\":\"PersistenceMR\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/18d9560171302ebe57c2181a282ed6c03220fc9123f720b864fcb3f8d21102c1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/18d9560171302ebe57c2181a282ed6c03220fc9123f720b864fcb3f8d21102c1?s=96&d=mm&r=g\",\"caption\":\"PersistenceMR\"},\"sameAs\":[\"https:\/\/icrowdnewswire.com\/fc\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/persistencemr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025 - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/","og_locale":"en_US","og_type":"article","og_title":"PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025 - Business","og_description":"In a new report titled &lsquo;Non-Melanoma Skin Cancer Treatment Market: Global Industry Analysis 2012 &ndash; 2016 and Forecast 2017 &ndash; 2025,&rsquo; Persistence Market Research analyzes the&nbsp;global&nbsp;non-melanoma skin cancer treatment market&nbsp;over an eight year forecast period 2017 &ndash; 2025 and throws light on the various factors impacting revenue growth of the market over the said period. &hellip; Continue reading PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025 Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/","og_site_name":"Business","article_published_time":"2020-05-12T04:09:57+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1589256597.png","type":"","width":"","height":""}],"author":"PersistenceMR","twitter_card":"summary_large_image","twitter_misc":{"Written by":"PersistenceMR","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/","url":"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/","name":"PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025 - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1589256597.png","datePublished":"2020-05-12T04:09:57+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/6b713e3e642aff8d034fb2ac17ade840"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1589256597.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1589256597.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2020\/05\/12\/pmr-non-melanoma-skin-cancer-market-to-grow-at-stellar-cagr-6-4-during-the-forecast-period-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/6b713e3e642aff8d034fb2ac17ade840","name":"PersistenceMR","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/18d9560171302ebe57c2181a282ed6c03220fc9123f720b864fcb3f8d21102c1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/18d9560171302ebe57c2181a282ed6c03220fc9123f720b864fcb3f8d21102c1?s=96&d=mm&r=g","caption":"PersistenceMR"},"sameAs":["https:\/\/icrowdnewswire.com\/fc"],"url":"https:\/\/ipsnews.net\/business\/author\/persistencemr\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/10998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/62"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=10998"}],"version-history":[{"count":0,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/10998\/revisions"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=10998"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=10998"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=10998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}